This Biotech Lets Rare-Disease Families Invest In Its Gene Therapy

Rare-disease families can now invest in Mahzi Therapeutics' gene therapy, giving patients a financial stake in developing treatments for their own communities Rare-disease families can now invest in Mahzi Therapeutics' gene therapy, giving patients a financial stake in developing treatments for their own communities Read the full story on Forbes Business via the link below.